Christopher S Meldrum

Bio

Over his career Mr. Meldrum has worked extensively with development-stage biotechnology and medical device companies, helping to secure initial financing for several start-up ventures. Before joining Paradigm Mr. Meldrum worked as Licensing Associate for Purdue University where he managed the out-licensing of Purdue’s biotechnology and life sciences portfolio. Prior to his time at Purdue he worked for two years in the University of Minnesota’s technology transfer office. Over the course of his career he has successfully led negotiations for more than 80 fully-executed deals. From 1997 until 2002 he also served on the Board of Directors for one of these companies, Alaxis Biosciences, Inc. Before coming to Golden Pine Ventures Mr. Meldrum held the position of Director, Corporate Alliances, at Paradigm Genetics, a publicly-traded biotechnology company where he led business development efforts for both the healthcare and agriculture businesses. He held business development positions of increasing responsibility since joining the company in the summer of 2000. During his time at Paradigm he negotiated to completion 7 revenue-generating collaborations with deal values totaling over $30 million. Mr. Meldrum received his MBA from the Carlson School of Management at the University of Minnesota, and his B.A. in Chemistry from the University of Utah.